Howe Jolanda

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$486,413.23

Insider Activity of Howe Jolanda

According to the SEC Form 4 filings, Howe Jolanda, being in a position of

  1. SVP, GLOBAL CONTROLLER at Mirum Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5591 share for $257,150,
    over all time since 2023-07-03, has bought 0 shares, and sold 13728 shares for $486,413.

The largest sale of all time was on 2024-11-14 and amounted to 2500 shares of Mirum Pharmaceuticals, Inc. for $117,752.

Biography of Howe Jolanda

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$257,1505100

Comparison of Insiders on Amount of Buys and Sells

2025-02-03SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, GLOBAL CONTROLLER
1,064
0.0022%
$48.22$51,309+3.23%
2025-01-24SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, GLOBAL CONTROLLER
902
0.0019%
$47.92$43,228+2.84%
2025-01-07SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, GLOBAL CONTROLLER
750
0.0016%
$42.82$32,111+15.22%
2024-11-14SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, GLOBAL CONTROLLER
2,500
0.0053%
$47.10$117,752-2.66%
2024-07-02SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, GLOBAL CONTROLLER
375
0.0008%
$34.00$12,750+23.78%
2024-02-02SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, GLOBAL CONTROLLER
735
0.0015%
$26.19$19,251+46.91%
2024-01-08SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, GLOBAL CONTROLLER
528
0.0011%
$28.04$14,803+29.73%
2023-12-05SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, Global Controller
2,500
0.0053%
$32.40$81,000-2.85%
2023-08-25SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, Global Controller
3,459
0.0089%
$26.23$90,743+8.35%
2023-07-03SaleMirum Pharmaceuticals, Inc.
MIRM
SVP, Global Controller
915
0.0024%
$25.65$23,467+5.81%
Total: 10
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD